Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Thomas HR, Hu B, Boyraz B, Johnson A, Bossuyt VI, Spring L, et al. Metaplastic breast cancer: A review. Crit Rev Oncol Hematol. 2023;182:103924.

Lam H, Saoud C, Shi Q, Wong KS, Cibas ES, Rooper LM, et al. Degenerative atypia in benign thyroid nodules: a potential diagnostic pitfall on fine-needle aspiration. J Am Soc Cytopathol. 2023;12(5):341-350.

Stagg J, Golden E, Wennerberg E, Demaria S. The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Sci Immunol. 2023;8(85):eabq3015.

Castrodad-Rodríguez CA, Cheng J, Westerhoff M, Liang GH, Lin J, Nalbantoglu I, et al. Clinical and Pathological Correlation in Concomitant Celiac Disease and Eosinophilic Esophagitis Suggests Separate Etiologies. Int J Surg Pathol. 2023:10668969231167526.

Liu L, Yang HS, Xu Z, Meng L, Lu Y, Han L, et al. Explore the impact of abnormal coagulation test results on pregnancy complications and perinatal outcomes by establishing the trimester-specific reference intervals of singleton and twin pregnancies. Clin Chim Acta. 2023;541:117265.

Oh W-, Yang Y-, Xie J, Ma H, Kim J-, Park K-, et al. WNT-modulating gene silencers as a gene therapy for osteoporosis, bone fracture, and critical-sized bone defects. Mol Ther. 2023;31(2):435-453.

Geng C, Zhang M-, Manyam GC, Vykoukal JV, Fahrmann JF, Peng S, et al. SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression. Clin Cancer Res. 2023;29(21):4464-4478.

Hwang JK, Magro CM, Lipner SR. Nail Unit Arteriovenous Hemangioma Presenting as Longitudinal Erythronychia. Skin Appendage Disord. 2023;9(4):300-305.

Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, et al. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. Neurooncol Adv. 2023;5(1):vdad076.

Bandini C, Mereu E, Paradzik T, Labrador M, Maccagno M, Cumerlato M, et al. Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma. Exp Hematol Oncol. 2023;12(1):71.